RATIONALE: The development of experimental models that readily translate between animals and humans is required to better integrate and clarify the biological, behavioural and cognitive mechanisms that underlie normal fear and pathological anxiety. Inhalation of low concentrations of carbon dioxide (CO(2)) increases anxiety and autonomic arousal in humans, triggers related behaviours in small animals, and increases selective attention to threat in healthy humans. However the effects on broader cognitive (non-emotional) processes that characterize anxiety are not known. OBJECTIVES: To examine the effect of 7.5 % CO(2) inhalation (vs. air) on the efficiency of discrete attention networks implicated in anxiety: alerting (maintaining an alert state), orienting (the selection of information from sensory input) and executive control (resolving cognitive conflict). METHODS:Twenty-three healthy human participants completed acomputerized Attention Network Test (ANT) during inhalation of 7.5 % CO(2) enriched and normal/medical air. Gas was administered blind to participants with inhalation order counterbalanced across participants. Measures of heart rate, blood pressure and subjective mood/anxiety were obtained at baseline and following each inhalation period. RESULTS:CO(2) inhalation increased anxiety, autonomic arousal and the efficiency of alerting and orienting attention network function. Autonomic response to CO(2) correlated with increased orienting; and CO(2)-induced anxiety, autonomic arousal and orienting network function increased with chronic (trait) anxiety. CONCLUSIONS: Evidence that CO(2) modulates attention mechanisms involved in the temporal detection and spatial location of salient stimuli converges with evidence that CO(2) triggers fear behaviour in animals via direct innervation of a distributed neural network that facilitates environmental hypervigilance.
RCT Entities:
RATIONALE: The development of experimental models that readily translate between animals and humans is required to better integrate and clarify the biological, behavioural and cognitive mechanisms that underlie normal fear and pathological anxiety. Inhalation of low concentrations of carbon dioxide (CO(2)) increases anxiety and autonomic arousal in humans, triggers related behaviours in small animals, and increases selective attention to threat in healthy humans. However the effects on broader cognitive (non-emotional) processes that characterize anxiety are not known. OBJECTIVES: To examine the effect of 7.5 % CO(2) inhalation (vs. air) on the efficiency of discrete attention networks implicated in anxiety: alerting (maintaining an alert state), orienting (the selection of information from sensory input) and executive control (resolving cognitive conflict). METHODS: Twenty-three healthy humanparticipants completed a computerized Attention Network Test (ANT) during inhalation of 7.5 % CO(2) enriched and normal/medical air. Gas was administered blind to participants with inhalation order counterbalanced across participants. Measures of heart rate, blood pressure and subjective mood/anxiety were obtained at baseline and following each inhalation period. RESULTS:CO(2) inhalation increased anxiety, autonomic arousal and the efficiency of alerting and orienting attention network function. Autonomic response to CO(2) correlated with increased orienting; and CO(2)-induced anxiety, autonomic arousal and orienting network function increased with chronic (trait) anxiety. CONCLUSIONS: Evidence that CO(2) modulates attention mechanisms involved in the temporal detection and spatial location of salient stimuli converges with evidence that CO(2) triggers fear behaviour in animals via direct innervation of a distributed neural network that facilitates environmental hypervigilance.
Authors: E Serap Monkul; Elif Onur; Umit Tural; John P Hatch; Tunç Alkın; Baris Yücel; Hüray Fidaner Journal: Psychiatry Res Date: 2010-05-16 Impact factor: 3.222
Authors: S D Hood; J K Melichar; L G Taylor; N Kalk; T R Edwards; D A Hince; A Lenox-Smith; A R Lingford-Hughes; D J Nutt Journal: J Psychopharmacol Date: 2010-01-21 Impact factor: 4.153
Authors: Adam E Ziemann; Jason E Allen; Nader S Dahdaleh; Iuliia I Drebot; Matthew W Coryell; Amanda M Wunsch; Cynthia M Lynch; Frank M Faraci; Matthew A Howard; Michael J Welsh; John A Wemmie Journal: Cell Date: 2009-11-25 Impact factor: 41.582
Authors: Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer Journal: World J Biol Psychiatry Date: 2016-07-15 Impact factor: 4.132
Authors: Stefanie Russman Block; Anthony P King; Rebecca K Sripada; Daniel H Weissman; Robert Welsh; Israel Liberzon Journal: Cogn Affect Behav Neurosci Date: 2017-04 Impact factor: 3.282
Authors: Susan Bamford; Ian Penton-Voak; Verity Pinkney; David S Baldwin; Marcus R Munafò; Matthew Garner Journal: J Psychopharmacol Date: 2015-03-10 Impact factor: 4.153
Authors: Ben Ainsworth; Jemma E Marshall; Daniel Meron; David S Baldwin; Paul Chadwick; Marcus R Munafò; Matthew Garner Journal: J Psychiatr Res Date: 2015-02-12 Impact factor: 4.791
Authors: Verity Pinkney; Robin Wickens; Susan Bamford; David S Baldwin; Matthew Garner Journal: J Psychopharmacol Date: 2014-06-04 Impact factor: 4.153